Gene · 8438
Papers1,865
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 1,865
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Germline mutations in homologous recombination repair genes among Chinese pancreatic ductal adenocarcinoma patients detected using next-generation sequencing. | Mol Genet Genomic Med | 2023 | 36978154 | PubTator, text mining | PubMed |
| Homologous recombination deficiency signatures in gastrointestinal and thoracic cancers correlate with platinum therapy duration. | NPJ Precis Oncol | 2023 | 36964191 | PubTator, text mining | PubMed |
| Evidence for virus-mediated oncogenesis in bladder cancers arising in solid organ transplant recipients. | Elife | 2023 | 36961501 | PubTator, text mining | PubMed |
| Clinical outcome of biomarker-guided therapies in adult patients with tumors of the nervous system. | Neurooncol Adv | 2023 | 36915613 | PubTator, text mining | PubMed |
| In search of an ideal template for therapeutic genome editing: A review of current developments for structure optimization. | Front Genome Ed | 2023 | 36911237 | PubTator, text mining | PubMed |
| Function and Evolution of the Loop Extrusion Machinery in Animals. | Int J Mol Sci | 2023 | 36902449 | PubTator, text mining | PubMed |
| The Cellular Response to Complex DNA Damage Induced by Ionising Radiation. | Int J Mol Sci | 2023 | 36902352 | PubTator, text mining | PubMed |
| Prognostic value of genomic mutations in metastatic prostate cancer. | Heliyon | 2023 | 36895385 | PubTator, text mining | PubMed |
| Potential miRNA biomarkers and therapeutic targets for early atherosclerotic lesions. | Sci Rep | 2023 | 36859458 | PubTator, text mining | PubMed |
| A Cell System-Assisted Strategy for Evaluating the Natural Antioxidant-Induced Double-Stranded DNA Break (DSB) Style. | Genes (Basel) | 2023 | 36833347 | PubTator, text mining | PubMed |
| Obesity promotes breast epithelium DNA damage in women carrying a germline mutation in BRCA1 or BRCA2. | Sci Transl Med | 2023 | 36812344 | PubTator, text mining | PubMed |
| Discovery of a new hereditary RECQ helicase disorder RECON syndrome positions the replication stress response and genome homeostasis as centrally important processes in aging and age-related disease. | Ageing Res Rev | 2023 | 36805074 | PubTator, text mining | PubMed |
| Hydroxylation markedly alters how the polychlorinated biphenyl (PCB) congener, PCB52, affects gene expression in human preadipocytes. | Toxicol In Vitro | 2023 | 36804509 | PubTator, text mining | PubMed |
| A novel DNA damage repair gene-related prognostic model for evaluating the prognosis and tumor microenvironment infiltration of esophageal squamous cell carcinoma. | BMC Med Genomics | 2023 | 36803971 | PubTator, text mining | PubMed |
| DNA repair deficiency as circulating biomarker in prostate cancer. | Front Oncol | 2023 | 36793600 | PubTator, text mining | PubMed |
| Suppression of GCH1 Sensitizes Ovarian Cancer and Breast Cancer to PARP Inhibitor. | J Oncol | 2023 | 36793373 | PubTator, text mining | PubMed |
| Unravelling homologous recombination repair deficiency and therapeutic opportunities in soft tissue and bone sarcoma. | EMBO Mol Med | 2023 | 36779660 | PubTator, text mining | PubMed |
| Estimation of an Image Biomarker for Distant Recurrence Prediction in NSCLC Using Proliferation-Related Genes. | Int J Mol Sci | 2023 | 36769108 | PubTator, text mining | PubMed |
| Novel Candidate loci and Pathogenic Germline Variants Involved in Familial Hematological Malignancies Revealed by Whole-Exome Sequencing. | Cancers (Basel) | 2023 | 36765901 | PubTator, text mining | PubMed |
| Implementing HRD Testing in Routine Clinical Practice on Patients with Primary High-Grade Advanced Ovarian Cancer. | Cancers (Basel) | 2023 | 36765776 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8438/papers?page=13